Literature DB >> 34918245

Developments in Vaccine Adjuvants.

Farrhana Ziana Firdaus1, Mariusz Skwarczynski1, Istvan Toth2,3,4.   

Abstract

Vaccines, including subunit, recombinant, and conjugate vaccines, require the use of an immunostimulator/adjuvant for maximum efficacy. Adjuvants not only enhance the strength and longevity of immune responses but may also influence the type of response. In this chapter, we review the adjuvants that are available for use in human vaccines, such as alum, MF59, AS03, and AS01. We extensively discuss their composition, characteristics, mechanism of action, and effects on the immune system. Additionally, we summarize recent trends in adjuvant discovery, providing a brief overview of saponins, TLRs agonists, polysaccharides, nanoparticles, cytokines, and mucosal adjuvants.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adjuvants; Delivery systems; Immune stimulators; Innate and adaptive immunity; Nanoparticles; Subunit vaccines; Vaccination

Mesh:

Substances:

Year:  2022        PMID: 34918245     DOI: 10.1007/978-1-0716-1892-9_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  273 in total

1.  Vaccine development strategies for improving immunization: the role of modern immunology.

Authors:  Myron M Levine; Marcelo B Sztein
Journal:  Nat Immunol       Date:  2004-05       Impact factor: 25.606

2.  The eradication of smallpox, a success story for modern medicine and public health: what lessons for the future?

Authors:  Eugenia Tognotti
Journal:  J Infect Dev Ctries       Date:  2010-06-03       Impact factor: 0.968

Review 3.  Key roles of adjuvants in modern vaccines.

Authors:  Steven G Reed; Mark T Orr; Christopher B Fox
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

Review 4.  Vaccine development: From concept to early clinical testing.

Authors:  Anthony L Cunningham; Nathalie Garçon; Oberdan Leo; Leonard R Friedland; Richard Strugnell; Béatrice Laupèze; Mark Doherty; Peter Stern
Journal:  Vaccine       Date:  2016-10-18       Impact factor: 3.641

Review 5.  Modern subunit vaccines: development, components, and research opportunities.

Authors:  Peter Michael Moyle; Istvan Toth
Journal:  ChemMedChem       Date:  2013-01-11       Impact factor: 3.466

Review 6.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

Review 7.  Accelerating next-generation vaccine development for global disease prevention.

Authors:  Wayne C Koff; Dennis R Burton; Philip R Johnson; Bruce D Walker; Charles R King; Gary J Nabel; Rafi Ahmed; Maharaj K Bhan; Stanley A Plotkin
Journal:  Science       Date:  2013-05-31       Impact factor: 47.728

Review 8.  Lipids as Activators of Innate Immunity in Peptide Vaccine Delivery.

Authors:  Stacey Bartlett; Mariusz Skwarczynski; Istvan Toth
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

Review 9.  Peptide-based synthetic vaccines.

Authors:  Mariusz Skwarczynski; Istvan Toth
Journal:  Chem Sci       Date:  2015-12-17       Impact factor: 9.825

Review 10.  Vaccines for the 21st century.

Authors:  Isabel Delany; Rino Rappuoli; Ennio De Gregorio
Journal:  EMBO Mol Med       Date:  2014-04-06       Impact factor: 12.137

View more
  3 in total

Review 1.  The progress of peptide vaccine clinical trials in gynecologic oncology.

Authors:  Mi Tang; Jiang-Hui Cai; Hao-Yang Diao; Wen-Mei Guo; Xiao Yang; ShaSha Xing
Journal:  Hum Vaccin Immunother       Date:  2022-06-10       Impact factor: 4.526

Review 2.  Recent Developments in Metallic Nanomaterials for Cancer Therapy, Diagnosing and Imaging Applications.

Authors:  Dan Nicolae Păduraru; Daniel Ion; Adelina-Gabriela Niculescu; Florentina Mușat; Octavian Andronic; Alexandru Mihai Grumezescu; Alexandra Bolocan
Journal:  Pharmaceutics       Date:  2022-02-17       Impact factor: 6.321

3.  Chitosan/Calcium-Coated Ginsenoside Rb1 Phosphate Flower-like Microparticles as an Adjuvant to Enhance Immune Responses.

Authors:  Xinghui Song; Huijuan Li; Liheng Zhang; Xiaozhan Zhang; Li Zhao; Gaiping Zhang; Shengbo Cao; Yunchao Liu
Journal:  Vet Sci       Date:  2022-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.